bb, I found those articles too but there is no mention of CCR5, Leronlimab or even Pro140 in those articles. The targets of the antibodies Cytodyn was aiming for are foreign to me.
Unless CCR5 was the target of the antibodies and trials, I don't think the cat studies were about Leronlimab. Do you?